Alcon Inc (NYSE:ALC)

$ 88.39 1.5 (1.73%) Market Cap: 43.97 Bil Enterprise Value: 46.92 Bil PE Ratio: 39.82 PB Ratio: 2.07 GF Score: 80/100

Half Year 2024 Alcon AG Earnings Call Transcript
Aug 21, 2024

$94.62 (-1.95%)

Earnings
Q1 2024 Alcon AG Earnings Call Transcript
May 14, 2024

$89.28 (+10.33%)

Earnings
Full Year 2023 Alcon AG Earnings Call Transcript
Feb 28, 2024

$85.69 (+5.56%)

Earnings
Alcon AG at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Alcon AG Earnings Call Transcript
Nov 15, 2023

$70.53 (-5.91%)

Earnings
Q2 2023 Alcon AG Earnings Call Transcript
Aug 16, 2023

$80.24 (+0.02%)

Earnings
Q1 2023 Alcon AG Earnings Call Transcript
May 10, 2023

$80.64 (+8.52%)

Earnings
Alcon AG Capital Markets Day Transcript
Mar 30, 2023
Full Year 2022 Alcon AG Earnings Call Transcript
Feb 28, 2023

$68.24 (-3.47%)

Earnings
Alcon AG at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Alcon AG Earnings Call Transcript
Nov 16, 2022

$66.33 (+4.67%)

Earnings
Half Year 2022 Alcon AG Earnings Call Transcript
Aug 10, 2022

$71.94 (-4.68%)

Earnings
Q1 2022 Alcon AG Earnings Call Transcript
May 11, 2022

$69.83 (+6.95%)

Earnings
Full Year 2021 Alcon AG Earnings Call Transcript
Feb 16, 2022

$80.53 (+2.16%)

Earnings
Alcon AG at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Q3 2021 Alcon AG Earnings Call Transcript
Nov 10, 2021

$82.64 (-5.29%)

Earnings
Alcon AG at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Half Year 2021 Alcon AG Earnings Call Transcript
Aug 18, 2021

$80.06 (+12.19%)

Earnings
Alcon AG Presents At Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Alcon AG Earnings Call Transcript
May 05, 2021

$70.04 (-6.02%)

Earnings
Q4 2020 Alcon AG Earnings Call Transcript
Feb 24, 2021

$70.04 (-2.70%)

Earnings
Alcon AG at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Q3 2020 Alcon AG Earnings Call Transcript
Nov 11, 2020

$64.9 (+0.26%)

Earnings
Alcon AG at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Q2 2020 Alcon AG Earnings Call Transcript
Aug 19, 2020

$59.84 (-2.24%)

Earnings
Alcon AG at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2020
Q1 2020 Alcon AG Earnings Call Transcript
May 13, 2020

$56.51 (+6.22%)

Earnings
Q4 2019 Alcon AG Earnings Call Transcript
Feb 26, 2020

$63.19 (+7.47%)

Earnings
Alcon AG at 38th Annual J.P Morgan Healthcare Conference Transcript
Jan 14, 2020
Q3 2019 Alcon AG Earnings Call Transcript
Nov 20, 2019

$56.89 (-3.72%)

Earnings
Alcon AG at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
Q2 2019 Alcon AG Earnings Call Transcript
Aug 21, 2019

$60.51 (-3.06%)

Earnings
Q1 2019 Alcon AG Earnings Call Transcript
May 16, 2019

$61.14 (+0.48%)

Earnings
Alcon AG at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019

Alcon AG at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 12:45PM GMT

Release Date Price: $86.44 (+2.97%)

Transcript

Cecilia E. Furlong

Morgan Stanley, Research Division - Equity Analyst

Thank you for joining us for the fourth day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Alcon with us today, David Endicott, CEO and Director; and Tim Stonesifer, CFO. And before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that, David, Tim, thank you for joining us today.

David J. Endicott

Alcon Inc. - CEO & Director

Thanks, Cecilia. It's been a pleasure to be here. A couple maybe just introductory remarks, if I may. I think we're really pleased with the quarter. I think it was strong growth, and it was largely driven by

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.